TARSUS PHARMACEUTICALS
Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.
TARSUS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.tarsusrx.com
Total Employee:
101+
Status:
Active
Contact:
(949) 409-9820
Email Addresses:
[email protected]
Total Funding:
585.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
BioPharma Credit
BioPharma Credit investment in Post-IPO Debt - Tarsus Pharmaceuticals
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Tarsus Pharmaceuticals
Armentum Partners
Armentum Partners investment in Post-IPO Debt - Tarsus Pharmaceuticals
Aperture Venture Partners
Aperture Venture Partners investment in Series B - Tarsus Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series B - Tarsus Pharmaceuticals
Visionary Venture Fund
Visionary Venture Fund investment in Series B - Tarsus Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Tarsus Pharmaceuticals
Flying L Partners
Flying L Partners investment in Series B - Tarsus Pharmaceuticals
Horowitz Group
Horowitz Group investment in Series B - Tarsus Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.tarsusrx.com Semrush global rank: 1.42 M Semrush visits lastest month: 18.04 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tarsus Pharmaceuticals"
Our Leadership - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We live our values of commitment, …See details»
Tarsus Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number (949) 409-9820 Tarsus Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address …See details»
Tarsus Pharmaceuticals, Inc. - Company Profile & Staff
*****@tarsusrx.com. View the complete 2024 Tarsus Pharmaceuticals, Inc. Employee List. Search Tarsus Pharmaceuticals, Inc. Staff Directory. Find accurate personal emails, work emails and …See details»
News Releases - Tarsus Pharmaceuticals
Aug 28, 2024 Dr. Yeu transitions from her role as Chief Medical Advisor and Board Member to lead the Company’s newly created Medical Organization IRVINE, Calif., Nov. 05, 2024 …See details»
Tarsus Pharmaceuticals, Inc. | LinkedIn
Tarsus recently partnered with Operation Gratitude, an organization whose mission is to extend appreciation to military and first responder communities. To honor their service, we helped …See details»
Tarsus Pharmaceuticals - Overview, News & Similar companies
May 8, 2024 Tarsus Pharmaceuticals contact info: Phone number: (949) 418-1801 Website: www.tarsusrx.com What does Tarsus Pharmaceuticals do? Founded in 2017, Tarsus …See details»
Investors & News | Tarsus Pharmaceuticals
Nov 6, 2024 Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to …See details»
Tarsus Announces Pricing of $100.0 Million Underwritten Public …
IRVINE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and apply …See details»
TP-05 - Tarsus
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science Our Values We live our values of commitment, …See details»
Tarsus Pharmaceuticals, Inc. - Facebook
Tarsus Pharmaceuticals, Inc. 437 likes · 10 talking about this. Tarsus is a biopharmaceutical that applies proven science to revolutionize treatment for...See details»
Tarsus Reports Third Quarter and Year-to-Date 2024 ... - Morningstar
Nov 13, 2024 Generated $48.1 million in XDEMVY ® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter. Strengthened payer coverage …See details»
Privacy Notice - Tarsus
If you are a resident of Nevada, you have the right to opt-out of the sale of certain Personal Data to third parties who intend to license or sell that Personal Data. You can exercise this right by …See details»
Tarsus Pharmaceuticals, Inc. Email Format | tarsusrx.com Emails
[email protected]: 75.5% [first] [email protected]: 24.5%. Email Verification Tool Instantly check any Tarsus Pharmaceuticals, Inc. email. Get free lookups per month. Verify Top Tarsus …See details»
Tarsus Announces Proposed $100.0 Million Public Offering | Tarsus ...
IRVINE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and apply …See details»
News Release - Tarsus Pharmaceuticals
IRVINE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new …See details»
Tarsus Pharmaceuticals, Inc. (@tarsusrx) - Instagram
1,005 Followers, 29 Following, 186 Posts - Tarsus Pharmaceuticals, Inc. (@tarsusrx) on Instagram: "A biopharmaceutical company that applies proven science and new technology to …See details»
Stock Information - Tarsus Pharmaceuticals
Nov 25, 2024 Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission Our Leadership Our experienced leaders are bound by passion and science …See details»
Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of ...
May 4, 2021 Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention Allows initiation of Phase 1 study to evaluate safety, …See details»
Pipeline Overview - Tarsus
A commitment to pursuing the root cause of disease. Lyme disease is the most common vector-borne disease in the United States, caused by an infection of Borrelia bacteria following a bite …See details»